- Home
- VRAX vs JXG Comparison
VRAX vs JXG Comparison
Compare VRAX & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- JXG
- Stock Information
- Founded
- VRAX 2013
- JXG N/A
- Country
- VRAX United Kingdom
- JXG China
- Employees
- VRAX N/A
- JXG N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- JXG
- Sector
- VRAX Health Care
- JXG
- Exchange
- VRAX Nasdaq
- JXG Nasdaq
- Market Cap
- VRAX 4.4M
- JXG 4.6M
- IPO Year
- VRAX 2022
- JXG N/A
- Fundamental
- Price
- VRAX $0.75
- JXG $0.97
- Analyst Decision
- VRAX Strong Buy
- JXG
- Analyst Count
- VRAX 1
- JXG 0
- Target Price
- VRAX $3.00
- JXG N/A
- AVG Volume (30 Days)
- VRAX 132.3K
- JXG 353.7K
- Earning Date
- VRAX 01-01-0001
- JXG 05-15-2025
- Dividend Yield
- VRAX N/A
- JXG N/A
- EPS Growth
- VRAX N/A
- JXG N/A
- EPS
- VRAX N/A
- JXG 0.86
- Revenue
- VRAX $6,331.00
- JXG $49,840,288.00
- Revenue This Year
- VRAX $217,274.83
- JXG N/A
- Revenue Next Year
- VRAX N/A
- JXG N/A
- P/E Ratio
- VRAX N/A
- JXG $1.16
- Revenue Growth
- VRAX N/A
- JXG 56.53
- 52 Week Low
- VRAX $0.72
- JXG $0.55
- 52 Week High
- VRAX $9.00
- JXG $8.40
- Technical
- Relative Strength Index (RSI)
- VRAX 38.90
- JXG N/A
- Support Level
- VRAX $0.72
- JXG N/A
- Resistance Level
- VRAX $0.80
- JXG N/A
- Average True Range (ATR)
- VRAX 0.07
- JXG 0.00
- MACD
- VRAX -0.01
- JXG 0.00
- Stochastic Oscillator
- VRAX 10.07
- JXG 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.